...
Other London events

Therapies of tomorrow

Please note this event takes place on the first floor, sorry there is no step-free access.
Past event - 2019
22 May Doors 7pm
Event 7.30-9.30pm
The Angelic, 57 Liverpool Rd,
London N1 0RJ
Sold Out!
Advances in biomedicine have increased our ability to detect diseases. However despite constant research we still can’t prevent the common cold and thousands of people are affected by debilitating inherited diseases. So, what does the future of medicine hold? Could genetic engineering be the future? Does physics have the answer to cancer treatment? And how can genetics improve antibiotic usage?

CRISPR Genome Editing: Better, Faster, CRISPR, Stronger

Dr Helen O’Neill (Lecturer in Reproductive and Molecular Genetics)
A genetic revolution has taken place in the mere 16 years since the human genome has been sequenced. This has shaped our understanding of evolution, treatment of disease and our interpretation of identity. We no longer look just to our mother, but to our molecules for reasons why we are the way we are. We can rely on deciphering our genetic code through mistakes; when a mutation occurs, we mine the molecules for a cause. But what if we could correct that mistake? Find out how CRISPR gene editing has the ability not just to fast forward our understanding of genetics, but alter our genomes.

Molecular Bionics meets Immunology: Improving Today's Nanomedicine

Chiara Cursi (PhD student)
In the Molecular Bionics lab we like playing with soft matter for improving Nanomedicine: physics, chemists and biologist are working side by side, taking inspiration from perfect structures and systems found in nature, in order to improve medicine at the nanoscale. One of the biggest challenges in medicine is to deliver the drugs you need just in the right site. Moreover, is it possible to use a synthetic delivery system in order to interact specifically with immune cells for improving cancer immunotherapies? Let’s find out together!

The Antibiotic Resistance Pandemic

Professor Francois Balloux (Professor of Computational Systems Biology)
Antibiotic resistance is a major clinical and public health problem. Hospitals worldwide are facing an increasing incidence of infections resistant to most, if not all antibiotics. Given the dearth of new compounds under development, our best hope to stem the antibiotic resistance pandemic is through more targeted prescription of existing drugs. I will overview how routine genome sequencing of clinical samples will allow developing improved diagnostics, better treatment and can help stem the spread of infections, whilst also being more cost-effective than current approaches.
Map data © OpenStreetMap contributors.